Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Should an ACE inhibitor be stopped if signs of renal insufficiency appear?
    Alejandro Morales, MD and Vincent W. Dennis, MD
    Cleveland Clinic Journal of Medicine April 2001, 68 (4) 280-282;

    One must consider the magnitude of the decline and the expected benefits of continuing the medication.

  • You have access
    Making the most of cholesterol-lowering margarines
    Julie K. Avery, RD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 194-196;

    These new “functional foods” reduce serum cholesterol and LDL levels modestly when used instead of regular margarine, butter, or oil. Are they worth it?

  • You have access
    Rare but serious adverse effects in commonly used drugs
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 179;

    Some adverse effects come to light only after millions of people have taken a drug.

  • Controlling irritable bowel syndrome
    You have access
    Controlling irritable bowel syndrome
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 237;
  • You have access
    Management of asymptomatic left ventricular dysfunction
    Garrie J. Haas, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 249-255;

    Heart failure can have an insidious onset, and the best time to intervene with ACE inhibitors and beta-blockers is early.

  • You have access
    The challenge of irritable bowel syndrome: Creating an alliance between patient and physician
    Bo Shen, MD and Edy Soffer, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 224-234;

    The key to treating irritable bowel syndrome is to establish a therapeutic physician-patient relationship.

  • You have access
    A 46-year-old man with dyspnea
    Curtis M. Rimmerman, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 191-192;

    Questions and answers on the visible signs of diseases.

  • You have access
    Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
    Donald G. Vidt, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 189-190;

    The new drugs have a lower side effect profile, but caution is indicated when giving them to patients with a history of ACE inhibitor-induced angioedema.

  • What are ‘tissue ACE inhibitors,’ and should they be used instead of other ACE inhibitors?
    You have access
    What are ‘tissue ACE inhibitors,’ and should they be used instead of other ACE inhibitors?
    Gary S. Francis, MD and John P. Gassler, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 185-186;

    Improvement in surrogate end points may not necessarily translate into improvement in “hard” clinical end points.

  • You have access
    Shedding: How to manage a common cause of hair loss
    Wilma F. Bergfeld, MD and Fabiane Mulinari-Brenner, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 256-261;

    Shedding is not a disease, but it sometimes is a sign of a disease.

Pages

  • Previous
  • Next
  • 1
  • …
  • 405
  • 406
  • 407
  • 408
  • 409
  • 410
  • 411
  • 412
  • 413
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire